rs56908561

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001291867.2(NHS):​c.3201T>C​(p.Ser1067Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00551 in 1,210,146 control chromosomes in the GnomAD database, including 198 homozygotes. There are 1,804 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.027 ( 111 hom., 841 hem., cov: 23)
Exomes 𝑓: 0.0033 ( 87 hom. 963 hem. )

Consequence

NHS
NM_001291867.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.575

Publications

0 publications found
Variant links:
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
NHS Gene-Disease associations (from GenCC):
  • Nance-Horan syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-17727307-T-C is Benign according to our data. Variant chrX-17727307-T-C is described in ClinVar as [Benign]. Clinvar id is 129774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.575 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0887 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSNM_001291867.2 linkc.3201T>C p.Ser1067Ser synonymous_variant Exon 7 of 9 ENST00000676302.1 NP_001278796.1 Q6T4R5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSENST00000676302.1 linkc.3201T>C p.Ser1067Ser synonymous_variant Exon 7 of 9 NM_001291867.2 ENSP00000502262.1 Q6T4R5-1

Frequencies

GnomAD3 genomes
AF:
0.0273
AC:
3058
AN:
112108
Hom.:
111
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0146
Gnomad ASJ
AF:
0.0117
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000372
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0125
Gnomad NFE
AF:
0.000413
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.00860
AC:
1576
AN:
183211
AF XY:
0.00585
show subpopulations
Gnomad AFR exome
AF:
0.0948
Gnomad AMR exome
AF:
0.00773
Gnomad ASJ exome
AF:
0.00709
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.00641
GnomAD4 exome
AF:
0.00329
AC:
3613
AN:
1097986
Hom.:
87
Cov.:
32
AF XY:
0.00265
AC XY:
963
AN XY:
363346
show subpopulations
African (AFR)
AF:
0.0932
AC:
2459
AN:
26393
American (AMR)
AF:
0.00909
AC:
320
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00722
AC:
140
AN:
19382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.000185
AC:
10
AN:
54142
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40520
Middle Eastern (MID)
AF:
0.00387
AC:
16
AN:
4136
European-Non Finnish (NFE)
AF:
0.000339
AC:
285
AN:
841911
Other (OTH)
AF:
0.00831
AC:
383
AN:
46090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
183
366
550
733
916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0273
AC:
3057
AN:
112160
Hom.:
111
Cov.:
23
AF XY:
0.0245
AC XY:
841
AN XY:
34354
show subpopulations
African (AFR)
AF:
0.0915
AC:
2816
AN:
30774
American (AMR)
AF:
0.0146
AC:
155
AN:
10625
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
31
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.000374
AC:
1
AN:
2677
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6161
Middle Eastern (MID)
AF:
0.0137
AC:
3
AN:
219
European-Non Finnish (NFE)
AF:
0.000413
AC:
22
AN:
53243
Other (OTH)
AF:
0.0189
AC:
29
AN:
1536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
105
210
315
420
525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0327
Hom.:
564
Bravo
AF:
0.0320
EpiCase
AF:
0.000382
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Inborn genetic diseases Benign:1
Nov 24, 2014
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nance-Horan syndrome Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.9
DANN
Benign
0.63
PhyloP100
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56908561; hg19: chrX-17745427; API